The King Khaled Eye Specialist Hospital & Research Center (KKESH&RC) Innovation Enablement Initiative (IEI) is a cornerstone program of our Innovation Unit. Established to ensure that cutting-edge ophthalmic solutions reach patients promptly and safely within the Kingdom of Saudi Arabia (KSA), the IEI provides a strategic, institutionally supported pathway for novel drugs, medical devices, and diagnostics. We serve as the essential bridge between global technological breakthroughs and local clinical integration, safeguarding patient well-being while advancing the standard of regional eye care.
عربي
Main Menu
Transformation Journey
Eye Health
Research Center
Physician Team
E-Services
Your Voice Service
Business Center
Innovation Enablement Initiative (IEI)
Our Core Objectives
The IEI is driven by a mandate to accelerate access to clinically impactful technologies and validate their effectiveness within the KSA environment. Our specific objectives are:
Accelerated Patient Access: To drastically reduce the timeline required for KSA patients to benefit from safe, effective, and globally recognized ophthalmic innovation.
Standardized Clinical Validation: To deploy a rigorous, consensus-based methodology for evaluating the clinical utility, operational feasibility, and safety profile of innovations, ensuring only the highest quality solutions are integrated into practice.
Targeted Regulatory Support: To mitigate critical market-entry challenges for innovators by providing expert guidance and institutional support through local regulatory frameworks.
IEI Enablement Pathways
The IEI offers three distinct, phase-appropriate programs, ensuring optimal resources are matched to the innovation's maturity and specific developmental needs.
1. Acceleration Pathway
This pathway is designed for true first-in-class innovations currently in the early stages of human testing.
Target Audience: Early-stage startup companies and developers with investigational products lacking international market approval (pre-FDA or pre-CE Mark).
Primary Focus: Enabling and executing early-stage clinical trials within the specialized research environment of KKESH&RC.
Key Outcome: Completion of a formal early-stage clinical trial, complete with data capture and regulatory documentation.
2. Regulation Pathway
This pathway is focused on overcoming the hurdles of local market entry for proven innovations.
Target Audience: Small and medium-sized companies whose products have secured major international regulatory approval (e.g., U.S. FDA or European CE Mark) but require local Saudi marketing authorization or registration
Primary Focus: Providing expert regulatory consultation, documentation guidance, and institutional liaison support necessary to navigate and complete the local submission and compliance validation processes.
Key Outcome: Successful achievement of local marketing authorization clearance of the local regulatory submission process.
3. Validation Pathway
This program targets market-ready innovations, focusing on generating local data and clinical consensus necessary for local procurement and widespread adoption.
Target Audience: Large pharmaceutical, device, and diagnostics manufacturers with products already approved internationally or pending local approval.
Primary Focus: Assessing the real-world operational feasibility, clinical fit, and local economic impact of the innovation through two specialized sub-tracks:
3A. Local Consensus Review
The primary focus is formal collection and synthesis of expert opinion and clinical consensus from KKESH&RC. The key outcome is a formal expert opinion report detailing adoption recommendation.
3B. Local Validation Study
The primary focus is execution of a small-scale, localized pilot research study to clinically validate key performance metrics or findings within the specific KSA patient population. The key outcome is a formal research report and localized validation data.
Begin Your Submission
The IEI accepts submissions from manufacturers, local distributors, and ophthalmologists acting as local investigators.
To formally apply for partnership under the IEI, please fill the IEI- Submission Form [Link] and send it via email to:
InnovationEnablement@kkesh.med.sa
Further Communication
For inquiries, technical questions regarding the application process, or clarification on program requirements, please contact us at:
InnovationEnablement@kkesh.med.sa